- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04464785
CentriMag Failure-to-Wean Post Approval Study
October 5, 2023 updated by: Abbott Medical Devices
CentriMag Failure-to-Wean Post-Approval Study
The primary objective of this Post Approval Study is to report the proportion of patients surviving to 30 days post CentriMag support or to hospital discharge, whichever is longer.
For subjects who do not recover and are bridged to a heart transplant or a long-term assist device, the primary endpoint is survival to induction of anesthesia for the surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
32
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hua-Wen Ding, MD, PhD
- Phone Number: +32488151239
- Email: huawen.ding@abbott.com
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Recruiting
- Baptist Healt Medical Center
-
Contact:
- Karol Mudy, MD
-
-
California
-
Palo Alto, California, United States, 94304
- Recruiting
- Stanford University Medical Center
-
Contact:
- William Hiesinger, MD
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Withdrawn
- University of Colorado
-
-
Florida
-
Orlando, Florida, United States, 32803
- Recruiting
- Advent Health Orlando
-
Contact:
- Scott Silvestry, MD
-
-
Illinois
-
Oak Lawn, Illinois, United States, 60453
- Recruiting
- Advocate Christ Medical Center
-
Contact:
- Antone Tatooles, MD
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48104
- Recruiting
- University of Michigan
-
Contact:
- Francis Pagani, MD
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Recruiting
- University of Minnesota Medical Center Fairview
-
Contact:
- Andrew Shaffer, MD
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Recruiting
- Barnes Jewish Hospital
-
Contact:
- Muhammad Masood, MD
-
-
New York
-
New York, New York, United States, 10032
- Recruiting
- New York Presbyterian/ Columbia University Medical Center
-
Contact:
- Koji Takeda, MD
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28206
- Recruiting
- Carolinas Medical Center
-
Contact:
- Eric Skipper, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- Hospital of The University of Pennsylvania
-
Contact:
- Christian Bermudez, MD
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- Recruiting
- University of Utah
-
Contact:
- Craig Selzman, MD
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Recruiting
- Medical College of Wisconsin
-
Contact:
- Lucian Durham, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Male and female subjects who fail-to-wean from cardiopulmonary bypass.
Description
Inclusion Criteria:
- Subject >18 years of age
- Subject or legal representative has signed Informed Consent Form (ICF)
- Subject has CentriMag Circulatory Support System implanted due to Failure To Wean from Cardiopulmonary Bypass
Exclusion Criteria:
• Concomitant use of Extracorporeal Membrane Oxygenation (ECMO) during CentriMag Circulatory Support System implantation due to FTW from CPB
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Treatment
Subjects who receive the CentriMag Circulatory Support System
|
The CentriMag Circulatory Suppose System is indicated for providing support for up to 30 days for one or both ventricles of the heart to treat post-cardiotomy patients who fail-to-wean from cardiopulmonary bypass, providing a bridge to decision when it is unclear whether the patient's heart will recover or whether the patient will need alternative, longer-term therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survival to 30 days Post CentriMag support or to hospital discharge
Time Frame: 30 days
|
The proportion of subjects who survive to 30 days post CentriMag support or to hospital discharge (whichever is longer).
|
30 days
|
Survival to induction of anesthesia for surgery for transplant or a long-term system
Time Frame: Approximately 30 days
|
The proportion of subjects who do not recover and are bridged to a transplant or long-term system
|
Approximately 30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sara Ahmed, Abbott
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 30, 2020
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
January 31, 2025
Study Registration Dates
First Submitted
July 7, 2020
First Submitted That Met QC Criteria
July 7, 2020
First Posted (Actual)
July 9, 2020
Study Record Updates
Last Update Posted (Actual)
October 6, 2023
Last Update Submitted That Met QC Criteria
October 5, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABT-CIP-10336
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Duke University; St. Paul's Hospital... and other collaboratorsActive, not recruitingHeart Diseases | Heart Failure | Transplant; Failure, Heart | Heart Transplant Failure and Rejection | Heart Failure,Congestive | Transplant FailureCanada, United States
Clinical Trials on CentriMag Circulatory Support System
-
Vivek ReddyAbiomed Inc.CompletedVentricular TachycardiaUnited States
-
Boston Scientific CorporationRecruitingHeart Disease, Coronary | High-risk Percutaneous Coronary InterventionUnited States, Sweden
-
Second Affiliated Hospital, School of Medicine,...CompletedTranscatheter Aortic Valve Replacement | Mechanical Circulatory SupportChina
-
Boston Scientific CorporationCompletedCoronary Artery DiseaseAustralia, Sweden
-
Kardion IncNot yet recruitingCoronary Artery Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure, CongestiveUnited States
-
Odense University HospitalCharite University, Berlin, Germany; Hannover Medical School; Aarhus University... and other collaboratorsCompletedAcute Myocardial Infarction | Cardiogenic Shock AcuteGermany, Denmark, United Kingdom
-
Abbott Medical DevicesThoratec CorporationWithdrawn
-
Abbott Medical DevicesThoratec CorporationCompletedHeart FailureUnited States